Perhaps a bit of a stand off here atm!
Will the market see value from here at $15 range, a recent high from Trof/Daybue's progress earlier this year.
Or will it see Neu is currently undervalued on Trof/Daybues own merits and add value with anticipation of upcoming results in Dec from PMS in 2591 a drug that has initially x 5 market value as Trof/Daybue.
Haven't really had a breakout of significance yet, which way will it go?
Are we going to stay in this range and bounce around $15 until read out, or will it be pushed lower to scare punters, shake out last few shares?
Share Price, page-7997
-
- There are more pages in this discussion • 4,825 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.27 |
Change
1.000(8.15%) |
Mkt cap ! $1.696B | |||
| Open | High | Low | Value | Volume |
| $12.95 | $13.39 | $12.79 | $9.854M | 751.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2545 | $13.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.29 | 1443 | 2 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |